189 related articles for article (PubMed ID: 28420716)
1. A MEN1 pancreatic neuroendocrine tumour mouse model under temporal control.
Lines KE; Vas Nunes RP; Frost M; Yates CJ; Stevenson M; Thakker RV
Endocr Connect; 2017 May; 6(4):232-242. PubMed ID: 28420716
[TBL] [Abstract][Full Text] [Related]
2. MiR-15a/miR-16-1 expression inversely correlates with cyclin D1 levels in Men1 pituitary NETs.
Lines KE; Newey PJ; Yates CJ; Stevenson M; Dyar R; Walls GV; Bowl MR; Thakker RV
J Endocrinol; 2018 Sep; 240(1):41-50. PubMed ID: 30389902
[TBL] [Abstract][Full Text] [Related]
3. Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia.
Harding B; Lemos MC; Reed AA; Walls GV; Jeyabalan J; Bowl MR; Tateossian H; Sullivan N; Hough T; Fraser WD; Ansorge O; Cheeseman MT; Thakker RV
Endocr Relat Cancer; 2009 Dec; 16(4):1313-27. PubMed ID: 19620250
[TBL] [Abstract][Full Text] [Related]
4. Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells.
Schnepp RW; Chen YX; Wang H; Cash T; Silva A; Diehl JA; Brown E; Hua X
Cancer Res; 2006 Jun; 66(11):5707-15. PubMed ID: 16740708
[TBL] [Abstract][Full Text] [Related]
5. Genetic background influences tumour development in heterozygous Men1 knockout mice.
Lines KE; Javid M; Reed AAC; Walls GV; Stevenson M; Simon M; Kooblall KG; Piret SE; Christie PT; Newey PJ; Mallon AM; Thakker RV
Endocr Connect; 2020 May; 9(5):426-437. PubMed ID: 32348957
[TBL] [Abstract][Full Text] [Related]
6. High-fidelity
Ackermann AM; Zhang J; Heller A; Briker A; Kaestner KH
Mol Metab; 2017 Mar; 6(3):236-244. PubMed ID: 28271030
[TBL] [Abstract][Full Text] [Related]
7. miR-3156-5p is downregulated in serum of MEN1 patients and regulates expression of MORF4L2.
Kooblall KG; Stokes VJ; Shariq OA; English KA; Stevenson M; Broxholme J; Wright B; Lockstone HE; Buck D; Grozinsky-Glasberg S; Yates CJ; Thakker RV; Lines KE
Endocr Relat Cancer; 2022 Oct; 29(10):557-568. PubMed ID: 35900839
[TBL] [Abstract][Full Text] [Related]
8. Two well-differentiated pancreatic neuroendocrine tumor mouse models.
Wong C; Tang LH; Davidson C; Vosburgh E; Chen W; Foran DJ; Notterman DA; Levine AJ; Xu EY
Cell Death Differ; 2020 Jan; 27(1):269-283. PubMed ID: 31160716
[TBL] [Abstract][Full Text] [Related]
9. Of mice and MEN1: Insulinomas in a conditional mouse knockout.
Crabtree JS; Scacheri PC; Ward JM; McNally SR; Swain GP; Montagna C; Hager JH; Hanahan D; Edlund H; Magnuson MA; Garrett-Beal L; Burns AL; Ried T; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
Mol Cell Biol; 2003 Sep; 23(17):6075-85. PubMed ID: 12917331
[TBL] [Abstract][Full Text] [Related]
10. Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.
Walls GV; Reed AA; Jeyabalan J; Javid M; Hill NR; Harding B; Thakker RV
Endocrinology; 2012 Nov; 153(11):5167-79. PubMed ID: 23024266
[TBL] [Abstract][Full Text] [Related]
11. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
12. [The role and mechanism of high expression of cyclin B2 in MEN1 insulinoma].
Wu T; Huang XH
Sheng Li Xue Bao; 2011 Dec; 63(6):555-64. PubMed ID: 22193451
[TBL] [Abstract][Full Text] [Related]
13. Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1.
Shen HC; He M; Powell A; Adem A; Lorang D; Heller C; Grover AC; Ylaya K; Hewitt SM; Marx SJ; Spiegel AM; Libutti SK
Cancer Res; 2009 Mar; 69(5):1858-66. PubMed ID: 19208834
[TBL] [Abstract][Full Text] [Related]
14. Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.
Hamze Z; Vercherat C; Bernigaud-Lacheretz A; Bazzi W; Bonnavion R; Lu J; Calender A; Pouponnot C; Bertolino P; Roche C; Stein R; Scoazec JY; Zhang CX; Cordier-Bussat M
Endocr Relat Cancer; 2013 Dec; 20(6):833-48. PubMed ID: 24157940
[TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia type 1 (MEN1).
Thakker RV
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):355-70. PubMed ID: 20833329
[TBL] [Abstract][Full Text] [Related]
16. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.
Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF
Int J Cancer; 2007 Jan; 120(2):259-67. PubMed ID: 17044021
[TBL] [Abstract][Full Text] [Related]
17. Analysis of p27(Kip1) expression in insulinomas developed in pancreatic beta-cell specific Men1 mutant mice.
Fontanière S; Casse H; Bertolino P; Zhang CX
Fam Cancer; 2006; 5(1):49-54. PubMed ID: 16528608
[TBL] [Abstract][Full Text] [Related]
18. Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues.
Biondi CA; Gartside MG; Waring P; Loffler KA; Stark MS; Magnuson MA; Kay GF; Hayward NK
Mol Cell Biol; 2004 Apr; 24(8):3125-31. PubMed ID: 15060136
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Management of Multiple Endocrine Neoplasia Type 1 (MEN1).
Dreijerink KM; Lips CJ
Hered Cancer Clin Pract; 2005 Feb; 3(1):1-6. PubMed ID: 20223025
[TBL] [Abstract][Full Text] [Related]
20. Clinically Defined Mutations in
Duan S; Sheriff S; Elvis-Offiah UB; Witten BL; Sawyer TW; Sundaresan S; Cierpicki T; Grembecka J; Merchant JL
Cancer Res Commun; 2023 Jul; 3(7):1318-1334. PubMed ID: 37492626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]